Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,182 | 3,952 | 827 | 404 | 1,243 |
| Receivables | N/A | 500 | N/A | N/A | N/A |
| Other current assets | 187 | 148 | 227 | 142 | 87 |
| TOTAL | $8,369 | $4,600 | $1,054 | $546 | $1,330 |
| Non-Current Assets | |||||
| PPE Net | 950 | 1,002 | 1,055 | 1,109 | 1,167 |
| TOTAL | $950 | $1,002 | $1,055 | $1,109 | $1,167 |
| Total Assets | $9,319 | $5,602 | $2,109 | $1,655 | $2,496 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 67 | 66 | 65 | 64 | 62 |
| Accounts payable and accrued liabilities | 626 | 607 | 571 | 634 | 645 |
| Accrued Expenses | 141 | 414 | 221 | 221 | 199 |
| Other current liabilities | N/A | N/A | N/A | 662 | N/A |
| TOTAL | $834 | $1,087 | $856 | $1,580 | $906 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,110 | 993 | 1,051 | 86 | 103 |
| TOTAL | $1,110 | $993 | $1,051 | $86 | $103 |
| Total Liabilities | $1,944 | $2,079 | $1,907 | $1,666 | $1,009 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47 | 39 | 37 | 37 | 37 |
| Common Shares | 155 | 6,369 | 6,123 | 6,123 | 6,123 |
| Retained earnings | -89,243 | -88,089 | -90,310 | -89,446 | -89,565 |
| TOTAL | $7,375 | $3,522 | $203 | $-12 | $1,487 |
| Total Liabilities And Equity | $9,319 | $5,602 | $2,110 | $1,655 | $2,496 |